Moving Forward in the Diagnosis of Infectious Diseases in Resource Limited Countries:

Similar documents
EBOLA VACCINE: Where are we? How to move forward?

Background. Meeting Objective. Participants

Off-target (heterologous/non-specific) effects of vaccination

Epidemics emergency: what role for research?

OPEN LETTER Re: Cartridge prices, extended warranties and business in Russia and the People s Republic of China

Programme «Allocations de recherche pour une thèse au Sud (ARTS)» ARTS program

Tuberculosis OUR MISSION THE OPPORTUNITY

DEPARTMENT OF TROPICAL MEDICINE, TULANE UNIVERSITY MASTER OF PUBLIC HEALTH AND TROPICAL MEDICINE (MPH&TM) PROGRAM

Technical guidance note for Global Fund HIV proposals in Round 11

University of Technology, Jamaica

Laboratory Information for Public Health Excellence

The global classroom: Training the world s healthcare professionals

Identification of a problem, e.g., an outbreak Surveilance Intervention Effect

PUBLIC HEALTH PARASITOLOGY PHC 6513 Syllabus, Spring Semester 2014

International training programme

Section 1. Section Venue Registration Acknowledgement of Funding V: of 6

Teaching of public health in medical Schools for strengthening health systems performance

Human Rights - Increase Access to Medicines and Supply Chain

Ter illustratie, het NIDIAG project

Content. Introduction: Health in Zimbabwe. PSM Zimbabwe. Pag 3. Pag 4. Zimbabwe s Response: Key Achievements. Pag 5

Health Innovation. Innovation for health includes the. diagnostics and medical devices, as

The American Friends Scholarship Fund

Innovation in Global Health Governance: Critical Challenges and Key Issues in addressing Contemporary Health Crises in the World

The Role of the Health Service Administrator in TB Control. National Tuberculosis Control Programme

Federal Ministry of Education and Research

Management for the World Module: Assessing point-of-care diagnostics for resource-limited settings

AORTA MASTERCLASS 2015 Preliminary Programme

Invitation to Host Academy Event

Dr Paul Mundill Innostics Innostics Oy

KICK- OFF MEETING OF THE WIN- NETWORK ON INSECTICIDE RESISTANCE MONITORING AND MANAGEMENT May 2016 IRD Centre, Montpellier, FRANCE

Global health diagnostics: research, development and regulation. Workshop report

Our values- Innovation, Excellence, Networking, Integrity and Sustainability

Antimicrobial Therapy in Immunocompromised and Critically Ill Patients: Management and Perspectives Palazzo dei Congressi - LUGANO May 2014

European Forum for Good Clinical Practice. 26 November Management Centre Europe, Brussels, Belgium. Children s Medicines Working Party

PROPOSAL by Bangladesh, Barbados Bolivia, and Suriname. Prize Fund for Development of Low-Cost Rapid Diagnostic Test for Tuberculosis. Date:

National Health Research Policy

PDP Funders Group Briefing Paper Background. 2. Methods

THE ROYAL VETERINARY COLLEGE UNIVERSITY OF LONDON. Applies to the cohort commencing 2013

Strengthening Policies on the Harmful Use of Alcohol, Gender-Based Violence and Infectious Disease

How To Get A Phd At The University Of Sydney

MCGILL SUMMER INSTITUTE Infectious Diseases & Global Health

Horizon 2020 New Opportunities for Clinical Research in Europe

Neurological Disorders Summit

A Comprehensive Global Public Health

DXjj>\e\iXc?fjg`kXc :_`c[i\e gi\j\ekj1 DXk\ieXc Xe[ :_`c[ >cfyxc?\xck_1 N_Xk Pfl E\\[ kf Befn 9\]fi\ Pfl >f =i`[xp$jxkli[xp# DXp *($Ale\ (# )'(*

TRACKS INFECTIOUS DISEASE EPIDEMIOLOGY

The Healthy Asia Pacific 2020 Roadmap INTRODUCTION: THE HEALTHY ASIA PACIFIC 2020 INITIATIVE

Better Health Care and Lower Costs: Accelerating Improvement through Systems Engineering

Tuberculosis in children in Europe -the ptbnet

Pharmacovigilance in Public Health Programmes

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

Congress Theme: Global Event: Regionally Aligned: Educational Value: Committed:

Public Private Partnerships. the Western Pacific & Cambodia

SIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item May Hepatitis

CELL AND MOLECULAR MECHANICS IN BIOMECIDINE with a focus on CARDIOVASCULAR SYSTEMS

ECDC Annual Work Programme 2010

Canadian Public Health Laboratory Network. Core Functions of Canadian Public Health Laboratories

Vaccines Research & Development. Exhibitor

DEVELOPING WORLD HEALTH PARTNERSHIPS DIRECTORY

Health in the 2030 Agenda for Sustainable Development

Dublin Declaration. on Partnership to fight HIV/AIDS in Europe and Central Asia

Summary. Request for Advice

Mother-to-child transmission of HIV

Challenges and Promise Microbiology laboratories in sub- Saharan Africa

Le métier d'infectiologue en Europe. Bruno Hoen Université de Franche Comté CHU de Besançon EGI 14 janvier 2011

Next Generation Sequencing in Public Health Laboratories Survey Results

Association of Veterinary Consultants

Lessons from the Stanford HIV Drug Resistance Database

FOREWORD. Member States in 2014 places patients and communities at the heart of the response. Here is an introduction to the End TB Strategy.

Scientific Committee. Andrés Cervantes (ESMO, GEICO) Antonio González (ESMO, GEICO) Andrés Poveda (ESMO, GEICO) Jan B. Vermorken (ESMO, GEICO)

Waiting room Hopital Bon Samaritain, Limbe, Haiti 1972

Fogarty International Center LET S NOT REINVENT THE WHEEL*: RESPONDING TO NCDS WITH LESSONS FROM HIV

Prepaid Summit: Europe 2010 Conference & Expo Milan, Italy October 2010

WELCOME. Status of Tropical Disease in Tribal Communities Scientific Director Tropical Health Foundation Santa Marta, Colombia

Electronic Patient Management System epms Zimbabwe

How To Develop Leadership

Global Clinical Laboratory Testing Market Report: 2012 Edition

Core Functions and Capabilities. Laboratory Services

Guidelines for the Master s Program in Infection Biology and Epidemiology of the Faculty of Natural Science at the University of Basel

Contact centred strategies to reduce transmission of M. leprae

29th General Assembly Montréal, Canada 9-12 October Draft Agenda. Meeting venue: WEDNESDAY, 9 OCTOBER 2013

Annual conference May Budapest 2015

GRANT APPLICATION FORM: ORGANISING AN ESO EDUCATIONAL EVENT

Studying the EU: Current and Future Challenges

Content Introduction. Pag 3. Introduction. Pag 4. The Global Fund in Zimbabwe. Pag 5. The Global Fund Grant Portfolio in Zimbabwe.

CALL FOR APPLICATIONS

2011 One Voice Advocacy Summit Agenda February th, 2011 Washington, DC ADVOCACY TRAINING

2015 Annual Conference

Opportunities for African Participation in H2020. Research and Innovation Work Programme

Personalized Career Pathway

2013 International Energy Workshop

Goal 1; Objective B: Improve health care quality and patient safety: Performance measure

Questions and Answers on Universal Health Coverage and the post-2015 Framework

NATIONAL INSTITUTE OF PUBLIC HEALTH

Is it time for a new drug development paradigm?

State-Supported Health Insurance Research & Results Day

Guideline: Nutritional care and support for patients with tuberculosis

Systematic Reviews in Laboratory Animal Science

Big Data in Health Sciences An India Prospective

Transcription:

Moving Forward in the Diagnosis of Infectious Diseases in Resource Limited Countries: Diagnostic Technology Advances Organized by Fondation Mérieux & the American Academy of Microbiology Les Pensières Fondation Mérieux Conference Center Veyrier du Lac - France September 12 to 14, 2011 1

Steering Committee Institutions Ahimsa Partners American Academy of Microbiology American Academy of Microbiology APHP Bill and Melinda GATES Foundation FIND Fondation Mérieux Fondation Mérieux Fondation Mérieux Institute Pasteur of Dakar London School of Hygiene & Tropical Medicine Malaria Research and Treatment Center PATH RollBack Malaria Partnership Stop TB Department - WHO UNAIDS Université Cheik Anta Diop Proposed Representatives Jean François de Lavison Ann Reid Keith Klugman François Simon TBC Giorgio Roscigno Christophe Longuet Guy Vernet Valentina Picot Amadou A Sall Rosanna Peeling Ogobara Doumbo Bernhard Weigl Jan Van Erps Mario C. Raviglione Paul De Lay Souleymane Mboup 2

Background A critical factor in reducing the infectious disease burden in developing countries is the ability to provide accurate diagnosis and monitor response to treatment. New technologies are emerging to improve the diagnosis and monitoring of infectious diseases. Rapid molecular methods and integrated diagnostic platforms are among the most promising approaches, having an important role in the global control of infectious diseases. International organizations and governments of developing countries realize that strengthening laboratory capacity both at the central and point-ofcare levels is necessary to reduce the burden of infectious disease and achieve the Millennium Development Goals. In recognition of the critical constraints on the diagnosis of many infectious diseases affecting the developing world, Fondation Mérieux organizes an annual forum to discuss the current state and future potential of diagnostic technologies to address the pressing needs of developing countries. After three successful forums Moving Forward on tuberculosis, malaria and HIV organized respectively with the Global Laboratory initiative of the STOP TB Partnership & the World Health Organization in 2008, with the Roll Back Malaria Partnership in 2009 and with UNAIDS in 2010, the 2011 forum co-organized with the American Academy of Microbiology will focus on Current Diagnostic Technology Advances on infectious diseases. The format of the forum will provide with an opportunity to share knowledge and experiences, identify connections between fields that may rarely interact, generate new ideas, and identify promising areas for future research and introduction of these technologies in the needed settings. Among the questions to be addressed at the forum are: What are the greatest challenges and problems with respect to current laboratory technologies in the developing laboratory setting? What scientific and technological advances are on the horizon that might allow developing countries to leapfrog over current hurdles and radically expand laboratory capacity? How to facilitate integration of new tools? The Moving Forward Forum will provide a comprehensive look at the current state and future potential of diagnostic technologies to address the needs of developing countries. The objectives of this annual forum are to: Increase awareness of the importance of adequate diagnosis of infectious diseases in resource limited countries; Highlight the specific needs and the new perspectives in all dimensions to address appropriately diagnostics in these regions of the world; Learn about the diagnostic tools available and those in development Exchange lessons learned from ongoing initiatives and disciplines Agree on priorities and on how all actors can interact to move forward 3

September 12, 2011 17h30-18h15 Registration 18h15-18h30 Welcome Address 18h30-19h30 Keynote Lectures: -Burden of Infectious Diseases in Developing Countries -Global Diagnostics Landscape Kevin M. De Cock TBC 19h30 Welcome Dinner September 13, 2011 Challenges and Needs SESSION I 9h00 12h00 Chair by: Ann Reid Co- chair : TBC Diagnostic technologies for public health reference laboratories Niel Constantine Giorgio Roscigno Diagnostic technologies for the point of care setting Rosanna Peeling Joseph Fair 10h30 11h10 Coffee Break Delivery and adoption of new diagnostic technologies in resource limited settings Oyewale Tomori Integration of vertical disease programs into horizontal health systems Gates - TBC New business models for developing countries Jean François de Lavison 12h30 14h00 Lunch 4

SESSION II 14h00 18h30 Building from Successful Field Experiences in applied diagnostics Chair by: Jan Van Erps Co- chair : Souleymane Mboup TB field experiences Malaria field experiences Leopold Blanc Ogobara Doumbo HIV field experiences Rasmata Ouedraougo 15h30 16h00 Coffee Break (Other Disease field experiences) (Other Disease field experiences) HPV field experiences Marleen Boelaert Amadou A Sall Susan Keese Clinical trials in applied diagnostics John T. McDevitt 19h30 Dinner September 14, 2011 Research & Development: New approaches in diagnostics SESSION III 9h00 16h00 Chair by: Keith Klugman Co-chair: TBC Approaching high tech affordable diagnostics in low tech settings Wendy Stevens Sustainable diagnostics and diagnosis interventions: Promoting what works and best ways to deliver TBC 10h00 10h30 Coffee Break 5

New approaches at the reference laboratory level Resistance testing Pathogens Identification Ron Ballard Jean Noel New approaches at the point-of-care level RDTs: What is new? POC Molecular Diagnostics Arman Nabatiyan William Rodriguez Cephid-TBC 12h45 14h00 Lunch Emerging Diagnostic Technologies: Nano/Microfluidics technology Other technologies Robert S. Marks George Whitesides- TBC 15h30 Conclusion / Recommendations Meeting Cloture 6